Innovative drug stocks on the Hong Kong market performed strongly, with Ascletis Pharma (01672.HK) rising more than 9%, and Innovent Biologics (01801.HK), BeiGene (06160.HK), and Genting New Horizon (01952.HK) all gaining more than 5%. Zai Lab (09688.HK), and SinoBiopharm (01530.HK) rose more than 4%.
Innovative drug stocks on the Hong Kong market performed strongly, with Ascletis Pharma (01672.HK) rising more than 9%, and Innovent Biologics (01801.HK), BeiGene (06160.HK), and Genting New Horizon (01952.HK) all gaining more than 5%. Zai Lab (09688.HK), SinoBiopharm (01530.HK) rose more than 4%.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Ethereum Classic (ETC) Future Outlook and Highlights Analysis: PoW, Fixed Supply, and 2026 Halving Upgrade
-
2
What is BNB? An Analysis of Binance’s Exchange Token BNB Positioning and Value Logic
-
3
Why should we pay attention to Ethereum?
-
4
What is Bee Network (BEE)? Trading Channels and Risk Analysis
-
5
Where can Audius (AUDIO) be bought and sold?
-
6
Top 10 Global Crypto Trading Apps: Ranking and Evaluation Metrics Breakdown
-
7
The Evolution of Ethereum's Consensus Mechanism: The Journey and Impact from Proof of Work to Proof of Stake
-
8
How to Buy Ethereum? Beginner's Guide and Exchange Selection
-
9
A Comprehensive Guide to Stellar and XRP: Positioning, Ecosystems, and Future Outlook
-
10
How to buy, sell, and trade Hera Finance (HERA)? Which exchanges is it listed on?
Markets Today
Recommended Reading







